LAURA HICE: Open Payments
NPI 1831484013 · ORANGE PARK, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,628 in 82 payments from 17 companies in 2025. Trend: 2023 $839 · 2024 $1,335 · 2025 $1,628
Food & beverage: $1,545Education: $83
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 18 | $268 |
| GENZYME CORPORATION | 8 | $264 |
| ABBVIE INC. | 15 | $230 |
| Regeneron Healthcare Solutions, Inc. | 13 | $228 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 4 | $148 |
| Janssen Biotech, Inc. | 5 | $106 |
| LEO Pharma Inc. | 2 | $55 |
| Galderma Laboratories, L.P. | 3 | $51 |
| Botanix SB Inc | 2 | $49 |
| Organogenesis Inc. | 2 | $43 |
Products named: DUPIXENT, Bimzelx, SKYRIZI, TREMFYA, ILUMYA, ADBRY, NEMLUVIO, SOFDRA.
Industry payments across FL — which companies pay providers there.
